Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schaaf

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2022
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant TuberculosisJennifer A Hughes, Belén P Solans, Heather R Draper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2024
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-AnalysisYasmine N White, Belen P Solans, Paolo Denti, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2023
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosisAli Mohamed Ali, Belén P Solans, Anneke C Hesseling, et al.
Journal of the Pediatric Infectious Diseases Society|May 30, 2013
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in ChildrenJames A Seddon, Carlos M Perez-Velez, H Simon Schaaf, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Epidemiological insights into paediatric tuberculosis trends in the Western Cape, South AfricaLauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Pediatrics|January 6, 2026
Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023)Lauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2021
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in ChildrenKendra K Radtke, Anneke C Hesseling, J L Winckler, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trialAnthony J Garcia-Prats, Elin M Svensson, Jana Winckler, et al.
JMIR Pediatrics and Parenting|July 1, 2024
Chest X-Ray-Based Telemedicine Platform for Pediatric Tuberculosis Diagnosis in Low-Resource Settings: Development and Validation StudyJuan J Gómez-Valverde, Ramón Sánchez-Jacob, José Luis Ribó, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2022
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant TuberculosisJennifer A Hughes, Belén P Solans, Heather R Draper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2024
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-AnalysisYasmine N White, Belen P Solans, Paolo Denti, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2023
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosisAli Mohamed Ali, Belén P Solans, Anneke C Hesseling, et al.
Journal of the Pediatric Infectious Diseases Society|May 30, 2013
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in ChildrenJames A Seddon, Carlos M Perez-Velez, H Simon Schaaf, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Epidemiological insights into paediatric tuberculosis trends in the Western Cape, South AfricaLauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Pediatrics|January 6, 2026
Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023)Lauren R Brown, Mariette Smith, Cari van Schalkwyk, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric StudiesAli Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2021
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in ChildrenKendra K Radtke, Anneke C Hesseling, J L Winckler, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trialAnthony J Garcia-Prats, Elin M Svensson, Jana Winckler, et al.
JMIR Pediatrics and Parenting|July 1, 2024
Chest X-Ray-Based Telemedicine Platform for Pediatric Tuberculosis Diagnosis in Low-Resource Settings: Development and Validation StudyJuan J Gómez-Valverde, Ramón Sánchez-Jacob, José Luis Ribó, et al.
Pageof 18